Jing Li

Jing Li

Auto-generated profile, based on publicly available information

Jing Li

Department of Oncology, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, Guangdong 518107, P. R. China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 November 2023 in Radiotherapy and Oncology
Verified
Journal Article
Closed access
LCLin Chen
Lin Chen
JLJing Li
Jing Li
KLKunpeng Li
Kunpeng Li
JHJiang Hu
Jiang Hu
QLQingjie Li
Qingjie Li
LTLing-Long Tang
Ling-Long Tang

18 March 2021 in Ear, Nose & Throat Journal
Verified
Journal Article
Open access
PDF file
JLJing Li
Jing Li
YTYuejin Tao
Yuejin Tao
XSXinyi Shi
Xinyi Shi
We describe a case of spontaneous nasal septal abscess (NSA) in a 9-year-old child. We also reviewed the literatures in recent years and summarized the characteristics of NSA, such as gender, age, inducement, pathogenic bacteria, treatment, and prognosis. We found that this boy reported by us has the most extensive abscess. May be the delay of treatment was related to the recent fluctuation of COVID-19 epidemic in China. Fortunately, with the help of surgery and anti-infection treatment, the boy was discharged from the hospital without septal perforation or saddle nose.

26 September 2023 in Ear, Nose & Throat Journal
Verified
Journal Article
Open access
ZYZongpei Yang
Zongpei Yang
ZXZhen Xue
Zhen Xue
YTYuejin Tao
Yuejin Tao
XSXinyi Shi
Xinyi Shi
JLJing Li
Jing Li
Objective: To investigate the alteration of the systemic inflammatory status of patients with obstructive sleep apnea syndrome (OSAS) and the predictive value of heparin-binding protein (HBP) for OSAS. Methods: Patients with OSAS who were hospitalized in our hospital from 2020 January to 2022 December and diagnosed by polysomnography (PSG) (OSAS group, n = 79) were retrospectively studied and their relevant examination findings and demographic characteristics were recorded. Sex- and age-matched non-OSAS patients hospitalized at the same time were selected as the control group (control group, n = 28). Differences in peripheral blood neutrophil counts, lymphocyte counts, neutrophil-to-lymphocyte ratio (NLR), procalcitonin (PCT), and HBP were compared between the 2 groups. The predictive value of these markers for OSAS was analyzed using the receiver operating characteristic curve, and independent risk factors for OSAS were determined using logistic regression analysis. Peripheral blood was drawn from all patients in the fasting state of the morning. Results: The number of peripheral blood neutrophils, lymphocytes, and HBP was higher in the OSAS group than in the control group, and the differences were statistically significant ( P all <.05), while the differences in NLR and PCT between the 2 groups were not statistically significant ( P all >.05). Plasma HBP level had an area under the curve (AUC) of 0.79 ( P < .0001) in determining OSAS, with a sensitivity of 80.49% and a specificity of 70.83% and the best cutoff value was >10.73 ng/ml. Combining body mass index (BMI), neutrophil, lymphocyte, and HBP improved the predictive value of OSAS with an AUC of 0.89 ( P < .0001), a sensitivity of 80.49%, and a specificity of 87.50%. Logistic regression analysis showed that both BMI and HBP were independent risk factors for OSAS ( P BMI < .001, P HBP < .01), while neutrophils and lymphocytes were not ( P all >.05). Conclusions: This is the first study to objectively examine HBP in OSAS patients, and HBP is an independent risk factor that may serve as a diagnostic biomarker in OSAS. Patients with OSAS have an altered systemic inflammatory state and may be more prone to severe bacterial infections.

18 October 2023 in arXiv
Verified
Preprint
Open access
PDF file
YZYirong Zhou
Yirong Zhou
YWYanhuang Wu
Yanhuang Wu
YSYuhan Su
Yuhan Su
JLJing Li
Jing Li
JCJianyun Cai
Jianyun Cai
XQXiaobo Qu
Xiaobo Qu
Magnetic Resonance Imaging (MRI) plays an important role in medical diagnosis, generating petabytes of image data annually in large hospitals. This voluminous data stream requires a significant amount of network bandwidth and extensive storage infrastructure. Additionally, local data processing demands substantial manpower and hardware investments. Data isolation across different healthcare institutions hinders cross-institutional collaboration in clinics and research. In this work, we anticipate an innovative MRI system and its four generations that integrate emerging distributed cloud computing, 6G bandwidth, edge computing, federated learning, and blockchain technology. This system is called Cloud-MRI, aiming at solving the problems of MRI data storage security, transmission speed, AI algorithm maintenance, hardware upgrading, and collaborative work. The workflow commences with the transformation of k-space raw data into the standardized Imaging Society for Magnetic Resonance in Medicine Raw Data (ISMRMRD) format. Then, the data are uploaded to the cloud or edge nodes for fast image reconstruction, neural network training, and automatic analysis. Then, the outcomes are seamlessly transmitted to clinics or research institutes for diagnosis and other services. The Cloud-MRI system will save the raw imaging data, reduce the risk of data loss, facilitate inter-institutional medical collaboration, and finally improve diagnostic accuracy and work efficiency.